Endo Pharmaceuticals is a specialty-generic company focused on producing branded drugs, sterile injectables, opioid pain killers, and generic competitors to off-patent chemical entities. Despite ...

WILMINGTON, Del., Oct. 19, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC) announced today that it has entered into a definiti ...

One of the few things that pharmaceutical companies live for is to release life-changing drugs onto the public market. While pharmaceuticals do not expect to debut blockbuster drugs every year ...

Endo Pharmaceuticals’ plan to buy out pelvic care company American Medical Systems for $2.9 billion is another step in Endo’s quest to become more diversified, according to a report by Bloomberg ...

Endo Pharmaceuticals rapidly became a primary target of litigation filed by over a dozen U.S. states in 2017.Endo stands out amongst the other pharmaceutical companies being sued, and is much more ...

Endo Pharmaceuticals, BioDelivery Sciences Present Promising Data On New Chronic Pain Management Product Endo Pharmaceuticals has Everybody Interested as M&A Target Endo Pharmaceuticals ...

All cash flow is not created equal. S&P 500 +---% | Stock Advisor +---% Join The Motley Fool ...

The Federal Trade Commission has sued Endo Pharmaceuticals and several other drugmakers, saying they've entered "pay-for-delay" deals that postpone generic versions of its drugs to hit the market.

SAN FRANCISCO (MarketWatch) -- Endo Pharmaceuticals Holdings Inc. endp after Thursday's closing bell said a unit has acquired all of the outstanding stock of RxKinetix Inc. for an initial payment ...

PHILADELPHIA (Legal Newsline) – Endo Health Solutions Inc. and its subsidiary, Endo Pharmaceuticals, have agreed to a $171.9 million settlement with the federal government to resolve off-label ...

SAN FRANCISCO (MarketWatch) -- An Endo Pharmaceuticals Holdings Inc. unit on Wednesday said it has received a subpoena from the Department of Health and Human Services, Office of Inspector General ...

BioSpecifics to be Acquired by Endo Pharmaceuticals Published. Oct 19, 2020 7:30am EDT - All cash transaction at $88.50 per share totaling $658 million in equity value - ...